Company Overview

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies.

Read More Corporate Presentation Corporate Fact Sheet

Latest News

IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022

November 22, 2022

IMUNON Announces Strategic Investment in Transomic Technologies

November 17, 2022

IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022

Financial Events

Imunon, Inc. Third Quarter 2022 Earnings Call

November 14, 2022 at 11:00 AM EST

Imunon Corporation Presentation_Chardan’s 6th Annual Genetic Medicines Conference

October 3, 2022 at 2:30 PM EDT